As little as needed: The extraordinary case of a mild recessive osteopetrosis owing to a novel splicing hypomorphic mutation in the TCIRG1 gene

Cristina Sobacchi, Alessandra Pangrazio, Antonio González Meneses Lopez, Diego Pascual Vaca Gomez, Maria Elena Caldana, Lucia Susani, Paolo Vezzoni, Anna Villa

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Mutations in the TCIRG1 gene, coding for a subunit of the osteoclast proton pump, are responsible for more than 50% of cases of human malignant autosomal recessive osteopetrosis (ARO), a rare inherited bone disease with increased bone density owing to a failure in bone resorption. A wide variety of mutations has been described, including missense, nonsense, small deletions/insertions, splice-site mutations, and large genomic deletions, all leading to a similar severe presentation. So far, to the best of our knowledge, no report of a mild phenotype owing to recessive TCIRG1 mutations is present neither in our series of more than 100 TCIRG1-dependent ARO patients nor in the literature. Here we describe an 8-year-old patient referred to us with a clinical diagnosis of ARO, based on radiological findings; of note, no neurological or hematological defects were present in this girl. Surprisingly, we identified a novel nucleotide change in intron 15 of the TCIRG1 gene at the homozygous state, leading to the production of multiple aberrant transcripts, but also, more importantly, of a limited amount of the normal transcript. Our results show that a low level of normal TCIRG1 protein can dampen the clinical presentation of TCIRG1-dependent ARO. On this basis, a small amount of protein might be sufficient to rescue, at least partially, the severe ARO phenotype, and this is particularly important when gene therapy approaches are considered. In addition, we would also recommend that the TCIRG1 gene be included in the molecular diagnosis of mild forms of human ARO.

Original languageEnglish
Pages (from-to)1646-1650
Number of pages5
JournalJournal of Bone and Mineral Research
Volume29
Issue number7
DOIs
Publication statusPublished - 2014

Fingerprint

Osteopetrosis
Mutation
Genes
Phenotype
Proton Pumps
Bone Diseases
Osteoclasts
Bone Resorption
Genetic Therapy
Bone Density
Introns
Proteins
Nucleotides

Keywords

  • AUTOSOMAL RECESSIVE OSTEOPETROSIS
  • HYPOMORPHIC MUTATION
  • SPLICING DEFECT
  • TCIRG1

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

As little as needed : The extraordinary case of a mild recessive osteopetrosis owing to a novel splicing hypomorphic mutation in the TCIRG1 gene. / Sobacchi, Cristina; Pangrazio, Alessandra; Lopez, Antonio González Meneses; Gomez, Diego Pascual Vaca; Caldana, Maria Elena; Susani, Lucia; Vezzoni, Paolo; Villa, Anna.

In: Journal of Bone and Mineral Research, Vol. 29, No. 7, 2014, p. 1646-1650.

Research output: Contribution to journalArticle

@article{3e30ade3e5f74f9c96ea03d9a127570c,
title = "As little as needed: The extraordinary case of a mild recessive osteopetrosis owing to a novel splicing hypomorphic mutation in the TCIRG1 gene",
abstract = "Mutations in the TCIRG1 gene, coding for a subunit of the osteoclast proton pump, are responsible for more than 50{\%} of cases of human malignant autosomal recessive osteopetrosis (ARO), a rare inherited bone disease with increased bone density owing to a failure in bone resorption. A wide variety of mutations has been described, including missense, nonsense, small deletions/insertions, splice-site mutations, and large genomic deletions, all leading to a similar severe presentation. So far, to the best of our knowledge, no report of a mild phenotype owing to recessive TCIRG1 mutations is present neither in our series of more than 100 TCIRG1-dependent ARO patients nor in the literature. Here we describe an 8-year-old patient referred to us with a clinical diagnosis of ARO, based on radiological findings; of note, no neurological or hematological defects were present in this girl. Surprisingly, we identified a novel nucleotide change in intron 15 of the TCIRG1 gene at the homozygous state, leading to the production of multiple aberrant transcripts, but also, more importantly, of a limited amount of the normal transcript. Our results show that a low level of normal TCIRG1 protein can dampen the clinical presentation of TCIRG1-dependent ARO. On this basis, a small amount of protein might be sufficient to rescue, at least partially, the severe ARO phenotype, and this is particularly important when gene therapy approaches are considered. In addition, we would also recommend that the TCIRG1 gene be included in the molecular diagnosis of mild forms of human ARO.",
keywords = "AUTOSOMAL RECESSIVE OSTEOPETROSIS, HYPOMORPHIC MUTATION, SPLICING DEFECT, TCIRG1",
author = "Cristina Sobacchi and Alessandra Pangrazio and Lopez, {Antonio Gonz{\'a}lez Meneses} and Gomez, {Diego Pascual Vaca} and Caldana, {Maria Elena} and Lucia Susani and Paolo Vezzoni and Anna Villa",
year = "2014",
doi = "10.1002/jbmr.2203",
language = "English",
volume = "29",
pages = "1646--1650",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - As little as needed

T2 - The extraordinary case of a mild recessive osteopetrosis owing to a novel splicing hypomorphic mutation in the TCIRG1 gene

AU - Sobacchi, Cristina

AU - Pangrazio, Alessandra

AU - Lopez, Antonio González Meneses

AU - Gomez, Diego Pascual Vaca

AU - Caldana, Maria Elena

AU - Susani, Lucia

AU - Vezzoni, Paolo

AU - Villa, Anna

PY - 2014

Y1 - 2014

N2 - Mutations in the TCIRG1 gene, coding for a subunit of the osteoclast proton pump, are responsible for more than 50% of cases of human malignant autosomal recessive osteopetrosis (ARO), a rare inherited bone disease with increased bone density owing to a failure in bone resorption. A wide variety of mutations has been described, including missense, nonsense, small deletions/insertions, splice-site mutations, and large genomic deletions, all leading to a similar severe presentation. So far, to the best of our knowledge, no report of a mild phenotype owing to recessive TCIRG1 mutations is present neither in our series of more than 100 TCIRG1-dependent ARO patients nor in the literature. Here we describe an 8-year-old patient referred to us with a clinical diagnosis of ARO, based on radiological findings; of note, no neurological or hematological defects were present in this girl. Surprisingly, we identified a novel nucleotide change in intron 15 of the TCIRG1 gene at the homozygous state, leading to the production of multiple aberrant transcripts, but also, more importantly, of a limited amount of the normal transcript. Our results show that a low level of normal TCIRG1 protein can dampen the clinical presentation of TCIRG1-dependent ARO. On this basis, a small amount of protein might be sufficient to rescue, at least partially, the severe ARO phenotype, and this is particularly important when gene therapy approaches are considered. In addition, we would also recommend that the TCIRG1 gene be included in the molecular diagnosis of mild forms of human ARO.

AB - Mutations in the TCIRG1 gene, coding for a subunit of the osteoclast proton pump, are responsible for more than 50% of cases of human malignant autosomal recessive osteopetrosis (ARO), a rare inherited bone disease with increased bone density owing to a failure in bone resorption. A wide variety of mutations has been described, including missense, nonsense, small deletions/insertions, splice-site mutations, and large genomic deletions, all leading to a similar severe presentation. So far, to the best of our knowledge, no report of a mild phenotype owing to recessive TCIRG1 mutations is present neither in our series of more than 100 TCIRG1-dependent ARO patients nor in the literature. Here we describe an 8-year-old patient referred to us with a clinical diagnosis of ARO, based on radiological findings; of note, no neurological or hematological defects were present in this girl. Surprisingly, we identified a novel nucleotide change in intron 15 of the TCIRG1 gene at the homozygous state, leading to the production of multiple aberrant transcripts, but also, more importantly, of a limited amount of the normal transcript. Our results show that a low level of normal TCIRG1 protein can dampen the clinical presentation of TCIRG1-dependent ARO. On this basis, a small amount of protein might be sufficient to rescue, at least partially, the severe ARO phenotype, and this is particularly important when gene therapy approaches are considered. In addition, we would also recommend that the TCIRG1 gene be included in the molecular diagnosis of mild forms of human ARO.

KW - AUTOSOMAL RECESSIVE OSTEOPETROSIS

KW - HYPOMORPHIC MUTATION

KW - SPLICING DEFECT

KW - TCIRG1

UR - http://www.scopus.com/inward/record.url?scp=84903317955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903317955&partnerID=8YFLogxK

U2 - 10.1002/jbmr.2203

DO - 10.1002/jbmr.2203

M3 - Article

C2 - 24535816

AN - SCOPUS:84903317955

VL - 29

SP - 1646

EP - 1650

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 7

ER -